Literature DB >> 28662568

Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea.

Sean S Lee1, Kyoung Ae Kong2, Daehoon Kim3, Yeong-Min Lim3, Pil-Sung Yang3, Jeong-Eun Yi4, Minsuk Kim5, Kihwan Kwon4, Wook Bum Pyun4, Boyoung Joung3, Junbeom Park4.   

Abstract

AIMS: For healthy populations without comorbidities, whether prehypertension and impaired fasting glucose (IFG) are associated with new onset atrial fibrillation (AF) is not well known. METHODS AND
RESULTS: We included 366 507 subjects (age ≥20 years) not diagnosed with non-valvular AF from the Korean National Health Insurance Service-National Sample Cohort (NHIS-NSC) from 2003 to 2008. In total, 139 306 subjects diagnosed with AF-related comorbidities were excluded, and a 227 102 healthy population was followed up until 2013. The body mass index (BMI), blood pressure (BP), and fasting blood glucose (BG) level were acquired during National health check-ups. Subjects with IFG [hazard ratio (HR) 1.16, P = 0.017] had a higher AF risk and the diastolic BP (HR 1.11, P = 0.045) was a stronger indicator for an AF incidence than the systolic BP. After dividing the subjects into two mutually exclusive groups, AF incidence was increased dramatically by the combination effect of both prehypertension and an IFG in BMI <25 kg/m2 group, but, in BMI ≧25 kg/m2 group, did not show this tendency. An IFG related to AF risk was more prominent in the BMI <25 kg/m2 population (HR 1.18, P = 0.025) than those with a BMI ≥25 kg/m2, and subjects with both an IFG and prehypertension had a greater AF risk (HR 1.27, P = 0.016) than those without.
CONCLUSION: Even in a healthy Asian populations without comorbidities, prehypertension and IFG were important risk factors of AF. Specifically, when prehypertension, including systolic and diastolic BPs, was finally combined with the IFG, the risk of new onset AF was increased especially in the BMI <25 kg/m2 group. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation ; Body mass index ; Healthy population; Impaired fasting glucose ; Prehypertension

Mesh:

Substances:

Year:  2017        PMID: 28662568     DOI: 10.1093/eurheartj/ehx316

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  27 in total

1.  Association of changes in cardiovascular health levels with incident cardiovascular events and mortality in patients with atrial fibrillation.

Authors:  Seunghoon Cho; Pil-Sung Yang; Daehoon Kim; Seng Chan You; Jung-Hoon Sung; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Clin Res Cardiol       Date:  2022-07-13       Impact factor: 6.138

2.  Prehypertension is a comorbid state with autonomic and metabolic dysfunction.

Authors:  Mi-Hyang Jung; Sang-Hyun Ihm; Dong-Hyeon Lee; Young Choi; Woo-Baek Chung; Hae Ok Jung; Kyung-Soon Hong; Ho-Joong Youn
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-06       Impact factor: 3.738

3.  Effect of Helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes.

Authors:  Young-Il Kim; Young Ae Kim; Hak Jin Kim; Su-Hyun Kim; Yul Hwangbo; Jae Gyu Kim; Jae J Kim; Il Ju Choi
Journal:  Korean J Intern Med       Date:  2020-11-25       Impact factor: 2.884

4.  Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation.

Authors:  Daehoon Kim; Pil-Sung Yang; Seng Chan You; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Jung-Hoon Sung; Boyoung Joung
Journal:  J Am Heart Assoc       Date:  2021-12-10       Impact factor: 6.106

5.  Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study.

Authors:  Faris Ghazal; Holger Theobald; Mårten Rosenqvist; Faris Al-Khalili
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

Review 6.  Cardiovascular Research Using the Korean National Health Information Database.

Authors:  Eue Keun Choi
Journal:  Korean Circ J       Date:  2020-05-20       Impact factor: 3.243

7.  Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation.

Authors:  Hee Tae Yu; Pil-Sung Yang; Eunsun Jang; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  J Am Heart Assoc       Date:  2020-06-04       Impact factor: 5.501

Review 8.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

9.  The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.

Authors:  Yun Gi Kim; Kyung-Do Han; Jong-Il Choi; Ki Yung Boo; Do Young Kim; Suk-Kyu Oh; Kwang-No Lee; Jaemin Shim; Jin Seok Kim; Young-Hoon Kim
Journal:  Cardiovasc Diabetol       Date:  2019-10-01       Impact factor: 9.951

10.  Associations of hypertension burden on subsequent dementia: a population-based cohort study.

Authors:  Hyunjean Jung; Pil-Sung Yang; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.